Wat betsjut "Dúdlik"?
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Hûn Congenital Myasthenic Syndrome In Heideterrier (CMS-H)
Discover the importance of the DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers, a hereditary neuromuscular disorder affecting this unique dog breed. Early genetic screening helps breeders identify carriers and prevent the transmission of CMS, ensuring healthier litters. This precise DNA test detects mutations linked to CMS, allowing for informed breeding decisions and improved canine health. Regular testing supports responsible breeding practices and enhances the overall well-being of Heideterriers. Protect your dog’s future by choosing reliable CMS DNA testing today. Stay proactive in managing congenital health risks with advanced genetic tools.
Ofkoarting: CMS-H
Analysearre mutaasje: CHRNE c.1436_1437insG
Erfskip: Autosomaal recessyf
Acronym
CMS-H
Observearre frekwinsje
Klinyske earnst
Clinical klassifikaasje
Neuromuskulêre sykten
Analysearre mutaasje
CHRNE c.1436_1437insG
p.(S503Rfs*14)
p.(S503Rfs*14)
Mode fan erfskip
Autosomaal recessyf
Test gearfetting:
The DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers helps identify genetic mutations responsible for this inherited neuromuscular disorder. CMS causes muscle weakness and fatigue due to impaired nerve-to-muscle communication. Early detection through genetic testing enables breeders to make informed decisions and reduce the risk of passing the condition to offspring. This test is essential for maintaining the health and vitality of the Heideterrier breed. Regular screening supports responsible breeding and improves overall canine welfare.
Beskikber út it pakket: Basic
Dizze DNA-test is opnommen fanôf ús pakket Basic - en is ek diel fan 'e pakketten Basic, Standard, Advanced, Complete.
Besjoch DNA-testpakketten →Kies it pakket dat it bêste past by jo fokken of sûnensstrategy fan jo bisten.
Overview of Congenital Myasthenic Syndrome (CMS)
Congenital Myasthenic Syndrome (CMS) is a group of inherited neuromuscular disorders characterized by weakness and fatigue of voluntary muscles. This condition results from defects in the transmission of nerve impulses to muscles, leading to compromised muscle function. It is caused by genetic mutations that affect the proteins responsible for neuromuscular transmission, notably at the neuromuscular junction where nerve cells communicate with muscles.
Symptoms of CMS in Dogs
Dogs affected by CMS may exhibit a range of symptoms, including muscle weakness, exercise intolerance, and fatigue. Some dogs may also show signs of difficulty in swallowing, facial muscle weakness, and a tendency to collapse after exertion. These symptoms can vary in severity and may be mistaken for other conditions, making a proper diagnosis crucial for effective management.
Importance of DNA Testing for CMS
DNA testing plays a vital role in identifying genetic mutations associated with Congenital Myasthenic Syndrome. By analyzing specific genes known to be linked to CMS, veterinarians and breeders can better understand the genetic predisposition of individual dogs. This information is crucial for making informed breeding decisions and helps in managing the condition in affected dogs.
Behear en behanneling opsjes
Currently, there is no cure for Congenital Myasthenic Syndrome; however, management strategies are available to improve the quality of life for affected dogs. Treatment often includes the use of medications such as anticholinesterase agents, which can enhance neuromuscular transmission. Supportive care, including physical therapy and nutritional management, is also essential to help maintain muscle function and overall health.
Konklúzje
Congenital Myasthenic Syndrome is a serious condition that can significantly affect the life of a dog. Early diagnosis through DNA testing can facilitate proper management and care, ensuring that affected dogs receive the support they need to lead a fulfilling life. Understanding the implications of this condition is vital for dog owners, breeders, and veterinary professionals alike.
Ras erkend foar de test: Congenital Myasthenic Syndrome In Heideterrier (CMS-H)
- Heideterrier
- Smooth Fox Terrier
🧬 Interpretation of genotypes CMS-H
Genotype
Status
🟡 N/N
Non-carrier - Gjin risiko
🟡 N/CMS-H
Carrier - Gjin risiko
❌ CMS-H/CMS-H
Beynfloede - At Risk
FAQ: begripe de ynterpretaasje
Is in "Carrier" serieus?
Nee, it bist is oer it algemien sûn, mar kin de mutaasje oerjaan oan har neiteam.
Wat as in bist "oandwaande" is?
It draacht twa mutearre eksimplaren. Klinyske tekens wurde ferwachte ôfhinklik fan de sykte. It moat net fokt wurde.
Wêrom binne d'r ferskillen tusken manlik / froulik?
Guon sykten binne seks-keppele, sadat harren útdrukking fariearret ôfhinklik fan de bist syn seks.
Foarsizze Offspring
N/N (non-drager)
N/CMS-H (Carrier)
CMS-H/CMS-H (Beynfloede)
DNA Test FAQ
Wat detektearret dizze DNA-test?
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome In Heideterrier (CMS-H) in order to identify clear, carrier, or at-risk animals.
Wêrom testje in fokdier?
DNA-testen helpt fokkers om feiliger parings te plannen en it risiko te ferminderjen fan it oerdragen fan de mutaasje nei neiteam.
Wat is de erflike modus fan dizze test?
De erflike modus rapportearre foar dizze test is Autosomal Recessive.
Hokker mutaasje wurdt analysearre yn dizze test?
This test analyses the mutation CHRNE c.1436_1437insG.
Is in dragerdier needsaaklik beynfloede?
Net needsaaklik. Ynterpretaasje hinget ôf fan it erflik patroan en de resultearjende genotyp.
References
Herder Vanessa, Ciurkiewicz Malgorzata, Baumgärtner Wolfgang, Jagannathan Vidhya, Leeb Tosso. Frame-shift variant in the CHRNE gene in a juvenile dog with suspected myasthenia gravis-like disease. Anim Genet. 2017 Oct;48(5):625. doi: 10.1111/age.12558. Epub 2017 May 16.